NIPTなど | NIPT（出生前診断）・妊娠に関するお役立ちコラム | ページ 4

NIPTなど

NIPT（新型出生前診断）についての情報です。是非参考にしてみてください。

An overview of the PI3K/Akt/mTOR intracellular signaling pathway. Different extracellular stimuli, e.g., growth factors and insulin, mediate their effects by binding to receptors belonging to the receptor tyrosine kinase (RTK) family. This leads to activation of phosphatidylinositol-4,5-bisphosphate 3-kinase (PI3K). PI3K converts phosphatidylinositol (3,4)-bisphosphate (PIP2) into phosphatidylinositol (3,4,5)-trisphosphate (PIP3), which recruits Akt-kinase and stimulates the Akt phosphorylation by PDK1 and mTORC2, on the Thr308 and Ser473 sites, respectively. The activation of the PI3K/Akt pathway through the inhibition of TSC (tuberous sclerosis complex) leads to the activation of mTORC1. Inhibition of the tuberous sclerosis complex (TSC) results in the loss of its ability to convert the Ras homolog enriched in brain active form (RhebGTP) to the inactive GDP-bound form (Rheb-GDP) leading to the subsequent activation of mTORC1. PTEN acts antagonistically to PI3K in conversion of PIP2 to PIP3, functioning as an important negative control. Activation of mTORC1 leads to phosphorylation of p70 ribosomal protein S6 kinase (p70S6K) and 4EBP1 (eukaryotic initiation factor 4E-binding protein) which, in turn, phosphorylates the ribosomal protein S6 leading to protein translation and synthesis. Active mTORC1 blocks autophagy by inhibitory phosphorylation of the ULK1 complex comprising of autophagy-related proteins (UNC51-like kinase 1 (ULK1), the autophagy-related gene 13 (Atg13), and FAK-family interacting protein of 200 kDa (FIP200). 4E-BP1 prevents translation initiation by sequestering eukaryotic translation initiation factor 4E (eIF4E). mTOR phosphorylates the eukaryotic initiation factor 4E-binding protein 1 (4E-BP1), thereby preventing it from binding to eIF4E, thus liberating eIF4E to enable translation. FMRP (fragile X mental retardation protein) is the protein produced by FMR1gene. FMRP binds to CYFIP1 (cytoplasmic FMRP-interacting protein 1) to form FMRP-CYFIP1 complex that obstructs translation by binding to eIF4E, which is obliterated in fragile X syndrome. Fig 1. Thomas, Shilu Deepa, et al. ‘mTOR Signaling Disruption and Its Association with the Development of Autism Spectrum Disorder’. Molecules, vol. 28, no. 4, Feb. 2023, p. 1889. DOI.org (Crossref), https://doi.org/10.3390/molecules28041889.

自閉スペクトラム症の科学：mTOR経路と発達障害のつながり

2026.07.23
NIPTなど

知らなきゃ損！？妊娠初期に絶対受けたい！最新の出生前検査。

知らなきゃ損！？妊娠初期に絶対受けたい！最新の出生前検査。

シスタチオニンβ-シンターゼ欠損によるホモシスチン尿症【CBS】…

2026.07.29
NIPTなど

ヒロクリニック　個人情報　安心

プライバシーマーク（PrivacyMark）ついて

2025.08.22
NIPTなど

ISO 17025とは

2026.07.09
NIPTなど

ISO18385とは？

2026.07.14
NIPTなど

ヒロクリニックNIPT　NIPPT　新型出生前診断

法医学とはなんですか？

2026.07.14
NIPTなど

WHO　ARE　YOU？　キャラクター　イラスト

フクちゃんって？

2025.01.16
NIPTなど

WHO　ARE　YOU？　ちひろ先生　イラスト

ちひろ先生って？

2026.07.20
NIPTなど

1
…
3
4

ラインはこちら

Copyright (c) NIPT Hiro Clinic All Rights Reserved.